HomeCompareOBLN vs GBDC

OBLN vs GBDC: Dividend Comparison 2026

OBLN yields 65.57% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.00M in total portfolio value· pulled ahead in Year 7
10 years
OBLN
OBLN
● Live price
65.57%
Share price
$3.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$853.1K
Annual income
$213,279.01
Full OBLN calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — OBLN vs GBDC

📍 GBDC pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBLNGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBLN + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBLN pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBLN
Annual income on $10K today (after 15% tax)
$5,573.77/yr
After 10yr DRIP, annual income (after tax)
$181,287.16/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,801,836.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBLN + GBDC for your $10,000?

OBLN: 50%GBDC: 50%
100% GBDC50/50100% OBLN
Portfolio after 10yr
$10.85M
Annual income
$8,332,006.43/yr
Blended yield
76.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

OBLN
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Altman Z
-22.4
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBLN buys
0
GBDC buys
0
No recent congressional trades found for OBLN or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBLNGBDC
Forward yield65.57%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$853.1K$20.85M
Annual income after 10y$213,279.01$16,450,733.83
Total dividends collected$718.9K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: OBLN vs GBDC ($10,000, DRIP)

YearOBLN PortfolioOBLN Income/yrGBDC PortfolioGBDC Income/yrGap
1$17,257$6,557.38$12,492$1,791.70+$4.8KOBLN
2$29,041$10,575.99$16,527$3,160.58+$12.5KOBLN
3$47,708$16,633.36$23,588$5,904.90+$24.1KOBLN
4$76,584$25,536.82$37,141$11,901.65+$39.4KOBLN
5$120,257$38,311.84$66,205$26,463.38+$54.1KOBLN
6$184,899$56,223.86$137,452$66,612.65+$47.4KOBLN
7← crossover$278,632$80,790.63$342,372$195,298.53$63.7KGBDC
8$411,919$113,782.33$1,053,292$686,954.33$641.4KGBDC
9$597,960$157,206.82$4,111,439$2,984,416.95$3.51MGBDC
10$853,096$213,279.01$20,849,974$16,450,733.83$20.00MGBDC

OBLN vs GBDC: Complete Analysis 2026

OBLNStock

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Full OBLN Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this OBLN vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBLN vs SCHDOBLN vs JEPIOBLN vs OOBLN vs KOOBLN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.